ANN ARBOR, Mich., Feb. 04, 2025 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal ...
at the Starr Center and Wyndham Boston Beacon Hill Hotel in Boston, Massachusetts About ONL1204 Ophthalmic Solution ONL1204 is a novel, first-in-class small molecule Fas inhibitor designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback